Evidence map›Paper›PMID 42267140›Full record

ArticleComputational and structural biotechnology journal2026

BioPipelines: Accessible Computational Protein and Ligand Design for Chemical Biologists.

Gianluca Quargnali, Pablo Rivera-Fuentes

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Gianluca QuargnaliDepartment of Chemistry, University of Zurich, 8057 Zurich, Switzerland.ORCID https://orcid.org/0000-0001-5626-4273
Pablo Rivera-FuentesDepartment of Chemistry, University of Zurich, 8057 Zurich, Switzerland.ORCID https://orcid.org/0000-0001-8558-2828

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deep learning methods for protein structure generation, sequence design, and structure and property prediction have created unprecedented opportunities for protein engineering and drug discovery. However, using these tools often requires navigating incompatible software environments, diverse input/output formats, and high-performance computing infrastructure, any of which may hinder adoption by primarily experimental chemical biology laboratories. Here, we present BioPipelines, an open-source Python framework that allows researchers to define multistep computational design workflows in a few lines of code. Additionally, its robust yet modular architecture provides a straightforward way to expand the tool kit with different functionalities, particularly by leveraging coding agents, with little effort. The framework currently integrates over 40 tools encompassing structure generation, sequence design, structure prediction, compound screening, and analysis. The same workflow code can be prototyped interactively in a Jupyter notebook and then submitted for production-scale runs without modification. We demonstrate applications in inverse folding, gene synthesis,

Identifiers

PMID42267140
PMCPMC13243794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.